Anti-TRAIL Antibody

This polyclonal primary antibody from Antibodies.com targets TRAIL, also called TNF-related apoptosis-inducing ligand, a type II transmembrane cytokine encoded by the TNFSF10 gene that selectively drives extrinsic apoptosis in transformed cell lines. The reagent is raised in rabbit and supplied unconjugated as 100 µl of antiserum in a single-use vial, ready for immediate incorporation into western blot and ELISA workflows. Validated reactivity covers human TRAIL, supporting research into immune surveillance, tumor cell clearance, and downstream signaling through DR4 and DR5 death receptors. Aliquot upon arrival and store at -20 °C to preserve function through repeated freeze-thaw cycles; protect from light when handled at the bench.